Jongsoon Lee

Preparation, characterization, and pharmacological study of a novel long-acting FGF21 with a potential therapeutic effect in obesity.

S. Bae, Ha Hyung Kim, I. Choi, 2020, Biologicals : journal of the International Association of Biological Standardization.

1830-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice

S. Bae, I. Choi, D. Kim, 2020 .

991-P: Potential of a Novel Long-Acting Glucagon Analog, HM15136, for the Treatment of Obesity

Jin Young Kim, Sang-Hyun Lee, I. Choi, 2019, Diabetes.

HM10660A, a long-acting hIFN-α-2b, is a potent candidate for the treatment of hepatitis C through an enhanced biological half-life.

Taehoon Sim, Chaemin Lim, S. Bae, 2017, International journal of pharmaceutics.

The Challenge of Obesity Treatment: A Review of Approved Drugs and New Therapeutic Targets

J. Salles, R. B. Santos, B. Bonamichi, 2018 .

The Challenge of Obesity: A Review of Approved Drugs and New

J. Salles, R. B. Santos, B. Bonamichi, 2018 .